Seminar: Prof. Eric Munson, University of Kentucky
UWinChemBiochem Seminar Series - Fall 2017
Prof. Eric Munson
Department of Pharmaceutical Sciences
University of Kentucky
Title: “Solid-State NMR Studies of Crystalline and Amorphous Organic Solids: Applications to Pharmaceuticals”
Web: http://pharmacy.uky.edu/faculty/emu222/Eric-Munson
Monday, December 11, 2017 @ 3:00 p.m.
Room #186 Essex Hall
**Everyone Welcome**
Showing posts with label pharmaceuticals. Show all posts
Showing posts with label pharmaceuticals. Show all posts
Tuesday, December 5, 2017
Wednesday, September 20, 2017
Seminar: Yongchao Su (Merck, King of Prussia, PA) - Fri. Sep. 22, 2017 @ 2:00 p.m.
Seminar: Yongchao Su (Merck, King of Prussia, PA)
UWinChemBiochem Seminar Series - Fall 2017
Dr. Yongchao Su
Merck, King of Prussia, PA
Title: Chemical and Biophysical insights into Pharmaceutical Sciences from NMR
Friday, September 22, 2017 @ 2:00 p.m.
Room #186 Essex Hall
**Everyone Welcome**
***Note the early start time***
UWinChemBiochem Seminar Series - Fall 2017
Dr. Yongchao Su
Merck, King of Prussia, PA
Title: Chemical and Biophysical insights into Pharmaceutical Sciences from NMR
Friday, September 22, 2017 @ 2:00 p.m.
Room #186 Essex Hall
**Everyone Welcome**
***Note the early start time***
Labels:
Merck,
pharmaceuticals,
seminar,
Yongchao Su
Thursday, October 27, 2011
Ultra-fast magic-angle spinning NMR probe up and running
Prof. Rob Schurko's NMR group has recently taken delivery of an ultra-fast magic-angle spinning NMR probe, which will be used for acquiring high-resolution 1H NMR spectra of a variety of different materials, including solid pharmaceuticals. The probe was purchased for ca. $110,000 using funds obtained from an NSERC RTI (Research Tools and Instruments) Grant. To read the Daily News story on this amazing probe, click here!
Tuesday, May 25, 2010
Process could help drug companies with simpler quality assurance, student finds
[Excerpt from the University of Windsor Daily News - to see the full article, click here]Pharmaceutical companies may find it faster and easier to assure the quality of their drugs, thanks to the findings of a PhD student in chemistry.~
Nuclear magnetic resonance (NMR) spectroscopy—technology normally associated with medical diagnostics—is a simpler method than the time-consuming techniques pharmaceutical companies currently use to make sure drugs such as painkillers or allergy medications remain effective through the manufacturing process, said Hiyam Hamaed.
When drugs are made, they're created in liquid solution and then transformed into a solid state for manufacturing, packaging, and shipping. Some substances crystallize in varying forms; each of these polymorphs has different properties which can influence the way people metabolize drugs, as well as their shelf life, packing, and handling. To see what final form the polymorphs have taken, pharmaceutical companies will try to make single crystals out of their drugs for molecular X-ray analysis, which can be painstakingly slow or sometimes impossible, Hamaed said.
"The problem is obtaining a single crystal," said Hamaed, who defended her thesis last week. "This can be very difficult. Crystals can be very hard to make."
Hamaed said NMR can be used to analyze the molecular structure of solid pharmaceuticals, eliminating the need to form crystals. Her work focused on the hydrochloride salts, often the most stable forms of many solid pharmaceuticals. She found that NMR is a better method for determining the identity and purity of these pharmaceuticals when standard methods, such as X-ray diffraction, fail.
"These are very fast experiments," said chemistry professor Rob Schurko, Hamaed’s academic advisor. "We can take a snapshot and quickly confirm whether a polymorph has formed. Each NMR signature acts as a fingerprint for each type of pharmaceutical or polymorph."
[Excerpt from the University of Windsor Daily News - to see the full article, click here]
Nuclear magnetic resonance (NMR) spectroscopy—technology normally associated with medical diagnostics—is a simpler method than the time-consuming techniques pharmaceutical companies currently use to make sure drugs such as painkillers or allergy medications remain effective through the manufacturing process, said Hiyam Hamaed.
When drugs are made, they're created in liquid solution and then transformed into a solid state for manufacturing, packaging, and shipping. Some substances crystallize in varying forms; each of these polymorphs has different properties which can influence the way people metabolize drugs, as well as their shelf life, packing, and handling. To see what final form the polymorphs have taken, pharmaceutical companies will try to make single crystals out of their drugs for molecular X-ray analysis, which can be painstakingly slow or sometimes impossible, Hamaed said.
"The problem is obtaining a single crystal," said Hamaed, who defended her thesis last week. "This can be very difficult. Crystals can be very hard to make."
Hamaed said NMR can be used to analyze the molecular structure of solid pharmaceuticals, eliminating the need to form crystals. Her work focused on the hydrochloride salts, often the most stable forms of many solid pharmaceuticals. She found that NMR is a better method for determining the identity and purity of these pharmaceuticals when standard methods, such as X-ray diffraction, fail.
"These are very fast experiments," said chemistry professor Rob Schurko, Hamaed’s academic advisor. "We can take a snapshot and quickly confirm whether a polymorph has formed. Each NMR signature acts as a fingerprint for each type of pharmaceutical or polymorph."
[Excerpt from the University of Windsor Daily News - to see the full article, click here]
To read more about Dr. Schurko's research, visit his homepage at:
Labels:
Hiyam Hamaed,
nmr,
pharmaceuticals,
research,
Schurko,
solid-state NMR
Subscribe to:
Posts (Atom)

